Clinical Study

Tacrolimus Dose Modification in Hematopoietic Cell Transplant Recipients Following a Change in Therapy from Fluconazole to Voriconazole

Table 2

Mean changes in ratios following a switch from fluconazole to voriconazole.

Patient Tacrolimus
administration
Fluconazole and tacrolimusVoriconazole and tacrolimus
Fluconazole
Dose/Route
Mean ratio
(ng/mL)/(mg/kg)
SEMVoriconazole
Dose/Route
Mean ratio
(ng/mL)/(mg/kg)
SEM

1PO, BID400 mg PO QD359.163.8IV load,
400 mg PO BID
670.072.3
2PO, BID400 mg PO QD254.813.2IV load,
300 mg PO BID
886.9180.7
3IV, CI400 mg IV QD474.4101.1IV load,
300 mg PO BID
859.6204.5
4PO, BID400 mg IV QD642.077.1IV load,
300 mg IV BID
878.596.2
5PO, BID400 mg PO QD333.234.9IV load,
300 mg IV BID
953.3316.0

Pooled Mean412.758.0849.7173.9

PO: oral administration, IV: intravenous administration.
QD: once daily, BID: two times daily, CI: continuous infusion.
ratio: concentration/dose ratio.
SEM: standard error of the mean.